Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCQB - Delayed Quote USD

NervGen Pharma Corp. (NGENF)

Compare
1.9000
-0.0300
(-1.55%)
At close: February 27 at 3:45:00 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
Adams (William James) Senior Officer of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 --
Bayley (Brian Eric) Director of Issuer Exercise of options Mar 12, 2024 400,000
Ives (Glenn Antony) Director of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 --
Kaye (Randall E) Director of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 10,000
Kelly (Michael) Director of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 143,957
Mckerracher (Krista L) Director of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 5,758
PFP Biosciences Holdings LLC 10% Security Holder of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 --
Punnett, Harold 10% Security Holder of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 1,125,532
Radvak (William Joseph) Director of Issuer Acquisition or disposition carried out privately Mar 28, 2024 1,407,500
Ruffolo (John) Director of Issuer Acquisition or disposition under a prospectus Mar 28, 2024 --

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.